Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Experimental Hematology|July 26, 2005
Identification of progression markers in B-CLL by gene expression profilingSusann Fält, Mats Merup, Gösta Gahrton, et al.
American Journal of Hematology|November 26, 2014
X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosisMaria Åström, Victoria Hahn-Strömberg, Eva Zetterberg, et al.
Leukemia & Lymphoma|February 26, 2008
Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemiaHareth Nahi, Sören Lehmann, Sofia Bengtzen, et al.
Blood|April 9, 2005
Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemiaSusann Fält, Mats Merup, Gerard Tobin, et al.
Acta Oncologica (Stockholm, Sweden)|May 7, 2002
Symptoms, symptom distress and health-related quality of life in patients with polycythaemia vera or essential thrombocythaemia during treatment with interferon-alphaMats Merup, Wiveca Aberg, Eva Löfvenberg, et al.
Leukemia Research|November 17, 2007
The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemiaMohd Arifin Kaderi, Fiona Murray, Mattias Jansson, et al.
European Journal of Haematology|November 6, 2009
IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemiaMahmoud R Mansouri, Marie Sevov, Anna Aleskog, et al.
International Journal of Cancer|June 12, 2008
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activationKristin Gustafsson, Xiao Wang, Denise Severa, et al.
British Journal of Haematology|September 16, 2006
Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimensMats Merup, Vladimir Lazarevic, Hareth Nahi, et al.
Haematologica|May 12, 2004
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disordersGunnar Birgegård, Magnus Björkholm, Jack Kutti, et al.
Pageof 3